<DOC>
	<DOCNO>NCT02622568</DOCNO>
	<brief_summary>The purpose study investigate topical treatment Veregen™ 15 % ointment single therapeutic agent compare combination therapy Veregen ™ 15 % ointment single destructive treatment cryotherapy non-facial verruca vulgaris pediatric population . The investigator compare single combination treatment modality identical time point patient non-facial verruca vulgaris . One current option care non-facial verruca include cryotherapy , painful destructive method perform pediatric dermatology clinic . This study aim establish safety , non-invasivenature , efficiency , efficacy Veregen ™ 15 % ointment monotherapyfor non-facial verruca vulgaris pediatric population . The investigator hypothesize Veregen ™ 15 % ointment monotherapy non-invasively treat non-facial verruca vulgaris similar efficacy combination therapy single cryotherapy treatment follow topical application Veregen ™ ointment . This novel treatment modality useful pediatric dermatology community offer less invasive , painless option treatment non-facial verruca vulgaris .</brief_summary>
	<brief_title>Investigating Veregen ™ 15 % Ointment Treatment For Non-facial Verrucae Pediatric Patients : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Warts</mesh_term>
	<criteria>Male female ethnic background Age 6 year old 16 year old A clinical diagnosis nonfacial verruca vulgaris Able adhere study visit schedule , Veregen ™ treatment requirement , baseline cryotherapy treatment half patient Verruca size great 5 mm Medically unstable patient Patients immunosuppression Families decline participation Verruca may treat precede 4 week prior enrollment Verruca may locate face genitalia Verruca size le 5 mm</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>